MTOR and neoplasm: The upregulation of FASN enhances lipogenesis in tumor cells, mainly through activation of the AKT/mTOR signaling pathway, thereby contributing to the immunometabolic switch in the tumor microenvironment and enhancing tumor growth and proliferation.